The longevity biotech industry is rapidly expanding, and with it, the importance of understanding public perception. Our efforts are shaped by the insights we gain about how the public views our work, ensuring we communicate effectively and resonate with people’s values and expectations.
Our upcoming poll is a continuation of a series we conducted in 2022, which aimed to gauge public opinion on initiatives designed to extend healthy human lifespans and to assess the level of involvement desired from various stakeholders.
Every contribution brings us closer to unlocking valuable insights from the public, guiding the future of longevity initiatives. Join us in this essential endeavor to better understand and navigate the path forward in extending healthy human lives.
The Alliance for Longevity Initiatives (A4LI) is a 501(c)(4) nonprofit organization whose mission is to advance legislation and policies that aim to increase healthy human lifespan, with a focus on accelerating equitable access to next-generation therapies.